47 filings
Page 2 of 3
8-K
orwp vulzf
22 Jun 20
Entry into a Material Definitive Agreement
5:26pm
8-K
vq7uzgu0 p6
5 Jun 20
Regulation FD Disclosure
4:05pm
8-K
tpz kg424
19 May 20
Cue Biopharma Reports First Quarter 2020 Results, Updates ofCUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
4:06pm
8-K
ag55ilg 2jnh8onk0j
27 Mar 20
Entry into a Material Definitive Agreement
4:53pm
8-K
cvh zsufj5o2
17 Mar 20
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:23pm
8-K
0vew2z 775
2 Mar 20
Regulation FD Disclosure
4:22pm
8-K
xf7pxj wbxq
10 Feb 20
Entry into a Material Definitive Agreement
4:01pm
8-K
z1jqh3y
26 Nov 19
Entry into a Material Definitive Agreement
12:00am
8-K
p36 7a1l4swgj0nh
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
aapvww5rll
9 Oct 19
Departure of Directors or Certain Officers
4:06pm
8-K
lmcvqmlrtd
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
8-K
yfav1r8nt78 lo0z
6 Aug 19
Departure of Directors or Certain Officers
4:49pm
8-K
a1cpldj
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
8-K/A
d9cm5 9qb56c3
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
s8zlqxi1emhbsoc1jcjw
13 Nov 18
Entry into a Material Definitive Agreement
4:22pm
8-K
z9ynb3wv54an43z
8 Nov 18
Entry into a Material Definitive Agreement
8:13am
8-K
wbr9afe qhm
3 Aug 18
Departure of Directors or Certain Officers
4:05pm
8-K
smg 7uux2h86
12 Jul 18
Cue Biopharma Produces Immuno-STATTM Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
8:40am
8-K
uvp h5y2lpuz
26 Jun 18
Departure of Directors or Certain Officers
4:16pm
8-K
pcqy0 yjjldjd
25 Jun 18
Changes in Registrant's Certifying Accountant
4:15pm